ImmLab continues to expand our intellectual property portfolio with a proactive strategy to ensure maximum protection for developed and acquired technologies.
Stable, tested and effective staphylococcal vaccines
With its patented technology, Immunology Laboratories, Inc. (ImmLab) is able to develop new products in reaction to actual epidemiological situation due to emerging resistant bacterial strains. All of ImmLab´s intellectual property, technology and vaccine strains are patented. All microbial strains used for the manufacturing of the products are deposited in international collections according to the Budapest treaty.
Immunology Laboratories, Inc.
United States Patents
ImmLab has been granted multiple Patents from the United States Patent and Trademark Office for its “Compositions and Methods for Treatment of Microbial Infections”.
We have been granted a European patent, along with individual EU countries of Germany, United Kingdom, France, Czech Republic and Slovakia.
We have been granted and issued Patents in Canada,Hong Kong, Japan and South Korea.
Copyright © Immunology Laboratories, Inc. 2020 All rights reserved.